Apple, TSMC Lead IBD's Latest Growth Stocks Watch List
Investor's Business Daily identifies five stocks nearing key buy points, led by Apple's entry into the foldable phone market.
Investor's Business Daily (IBD) has released its latest weekend watch list, identifying five high-growth stocks currently positioned near their technical buy points. The list is headlined by tech giants Apple (AAPL) and Taiwan Semiconductor Manufacturing (TSM), signaling potential entry opportunities for investors tracking momentum breakouts.
According to the IBD report, the five companies currently nearing buy points are Apple, Taiwan Semiconductor Manufacturing, Twilio (TWLO), Oscar Health (OSCR), and Hinge Health (HNGE). A primary driver for the current focus on Apple is the company's recent unveiling of the iPhone Duo, its first-ever foldable iPhone, alongside two other new hardware models.
The CAN SLIM Framework
These selections are based on IBD's proprietary CAN SLIM investment strategy. This methodology prioritizes growth stocks that exhibit strong quarterly earnings and significant institutional sponsorship. Rather than buying stocks at random, the strategy focuses on identifying a "buy point"—a specific price level where a stock is breaking out of a consolidation pattern, suggesting a new upward trend is beginning.
Market Implications
The inclusion of both Apple and TSMC on the same list underscores the symbiotic relationship between the hardware designer and its primary chip manufacturer. The launch of the iPhone Duo represents a major strategic shift for Apple, as it enters a new product category that could trigger a hardware super-cycle. Because TSMC produces the advanced silicon required for such devices, any surge in foldable iPhone demand is expected to provide a direct tailwind for the semiconductor giant.
Beyond big tech, the list highlights specialized growth plays. Hinge Health, for instance, is noted for its digital management of musculoskeletal afflictions and its expansion into migraine care, which includes the use of the FDA-cleared Enso device.
What to Watch
Investors will be monitoring whether these five stocks successfully clear their buy points with sufficient volume to confirm a breakout. While the hardware launches provide a fundamental catalyst for Apple, the broader market will be looking for sustained institutional buying to validate the CAN SLIM signals. The performance of the iPhone Duo in its initial sales window will likely serve as a bellwether for the short-term trajectory of both AAPL and TSM.